AlphaFold predicted structure
IL21 · Q9HBE4

Mean pLDDT
83.4/ 100
Confident
162 residues
Confidence breakdown
- Very high(≥ 90)56%
- Confident(70–90)20%
- Low(50–70)19%
- Very low(< 50)5%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
interleukin 21
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
COVID-19 research
BIALLELIC, autosomal or pseudoautosomalInfantile enterocolitis & monogenic inflammatory bowel disease
BIALLELIC, autosomal or pseudoautosomalPrimary immunodeficiency or monogenic inflammatory bowel disease
BIALLELIC, autosomal or pseudoautosomalAutosomal recessive early-onset inflammatory bowel disease
hypothyroidism
Crohn disease
psoriasis
asthma
celiac disease
psoriasis vulgaris
neurodegenerative disease
inflammatory bowel disease
myxedema
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Interleukin-21
Cytokine with immunoregulatory activity. May promote the transition between innate and adaptive immunity. Induces the production of IgG(1) and IgG(3) in B-cells (By similarity). Implicated in the generation and maintenance of T follicular helper (Tfh) cells and the formation of germinal-centers. Together with IL6, control the early generation of Tfh cells and are critical for an effective antibody response to acute viral infection (By similarity). May play a role in proliferation and maturation of natural killer (NK) cells in synergy with IL15. May regulate proliferation of mature B- and T-cells in response to activating stimuli. In synergy with IL15 and IL18 stimulates interferon gamma production in T-cells and NK cells (PubMed:11081504, PubMed:15178704). During T-cell mediated immune response may inhibit dendritic cells (DC) activation and maturation (By similarity)
IL21 · Q9HBE4

Mean pLDDT
83.4/ 100
Confident
162 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0